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Pathogenic roles of post-heparin lipases in lipid abnormalities in he-
modialysis patients. The relative roles of hepatic lipase and lipoprotein
lipase in the pathogenesis of uremic lipid abnormalities were studied in
92 hemodialysis patients. Fasting serum cholesterol, triglyceride, and
HDL-cholesterol concentrations were measured. Plasma lipoprotein el-
ectrophoretic patterns were determined in all patients. Hepatic lipase
and lipoprotein lipase activities were selectively measured in post-hep-
arm plasma in 59 patients. Hemodialysis patients had higher serum tri-
glyceride and lower HDL-cholesterol concentrations than did their age
and sex-matched control subjects. Both hepatic and lipoprotein lipase
activities were reduced in hemodialysis patients. An inverse relation
between lipoprotein lipase activities and serum triglyceride concentra-
tions emerged. Lipoprotein lipase activities correlated with in vivo
post-heparin fractional clearance rates of Intralipid. A positive corre-
lation between lipoprotein lipase activities and HDL-cholesterol con-
centrations probably reflected impaired catabolism of triglyceride-rich
lipoproteins being responsible for the low HDL-cholesterol concentra-
tions. Hemodialysis patients (41.3%) had an abnormal lipoprotein (the
'mid-band'). While hepatic lipase activities did not correlate with any
parameters of lipid metabolism, patients with 'low' hepatic lipase ac-
tivities had a significantly higher prevalence of 'mid-bands' than did
those with 'normal' activities. No evidence was developed to prove
that the 'mid-band' lipoproteins were remnant particles.
Roles pathogenes des lipases post-hépariniques dans les anomalies
lipidiques des hémodialysés. Les roles relatifs de Ia lipase hepatique et
de Ia lipoproteine lipase dans Ia pathogenic des anomalies lipidiques de
l'urémie ont ete étudiés chez 92 malades hemodialysCs. Les concen-
trations seriques a jeün de cholesterol, de triglycerides et HDL-
cholesterol ont été mésurées. Les aspects electrophorétiques des
lipoproteines plasmatiques ont ete déterminés chez tous les malades.
Les activités lipases hepatiques et lipoprotéine lipase ant été mesurCes
sélectivement dans le plasma post-heparinique de 59 malades. Les
malades hemodialysés avaient des concentrations sériques de
triglycerides plus élevées et d'HDL-cholestérol plus faibles que leurs
sujets contrôles d'hge et de sexe identiques. Les activités lipase
hépatique et lipoproteine lipase étaient réduites chez les malades
hémodialysés. Une relation inverse entre les activités lipoprotéines
lipases et les concentrations seriques de triglycerides est apparue. Les
activités lipoproteines lipases étaient corrélées avec les clearances frac-
tionnelles post-héparine in-viva d'lntralipid. Une correlation positive
entre les activités lipoproteines lipases et les concentrations d'HDL
cholesterol reflétaient probablement une anomalie du catabolisme des
lipoproteines riches en triglycerides, responsables des faibles concen-
trations d'HDL-cholestérol. Les malades (41,3%) hémodialysés avai-
ent une lipoproteine anormale ("bande moyenne"). Alors que les
activités lipases hepatiques n'étaient pas corrélées avec aucun des
paramètres do métabolisme lipidique, les malades avec de faibles
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"activités" lipases hépatiques avaient une prevalence significative-
ment plus forte de "bandes moyennes" que ceux avec des activités "nor-
males." Aucune preuve n'a ete apportée que les lipoprotéines de Ia
"bande moyenne" étaient des particules restantes.
Low post-heparin lipolytic activities (PHLA) have been sug-
gested as an important part in causing uremic hypertriglycer-
idemia [1]. It is now recognized that PHLA consists of the
activities of two triglyceride lipases: hepatic lipase and lipopro-
tein lipase [2]. Two groups [3, 4] have reported a selective de-
ficiency of hepatic lipase in uremic patients while others have
claimed that lipoprotein lipase activities are reduced alone or
in association with the reduction in hepatic lipase activities [5,
6]. The reason for such discrepancies is not immediately clear.
Because lipoprotein lipase activity constitutes a small fraction
of PHLA [7, 8], studies in which [4] the lipoprotein lipase ac-
tivity was determined by a 'difference' method [7, 9] might fail
to detect differences in enzyme activities. In the following
study, hepatic lipase and lipoprotein lipase activities in post-hep-
arm plasma were measured in vitro, each under conditions op-
timal for its activity. The relation between the two enzyme ac-
tivities and other parameters of lipid metabolism was deter-
mined to assess the relative contributions of defects in the two
enzyme activities toward the pathogenesis of lipid abnormali-
ties in uremic patients on maintenance hemodialysis.
Methods
We studied 92 patients (53 males and 39 females) who had
endstage renal failure from various causes and were on main-
tenance hemodialysis. Their ages ranged from 17 to 71 years
with a mean of 39 years. All except one patient, who had a cre-
atinine clearance of about 2.5 mI/mm, had negligible glomeru-
lar filtration. Most patients were self-care patients who dia-
lyzed at home while a few were hospitalized dialysis patients.
None were hypoalbuminemic. Hemodialysis was carried out
for 18 to 21 hr/week using a variety of artificial dialysers. The
dialysate had a glucose concentration of 1.8 g/Iiter and an ace-
tate concentration of 35 mmoles/liter when reconstituted. Se-
quential diafiltration was not used. The duration of dialysis
ranged from 6 months to 15 years with a mean of 6.5 years. All
except four patients were within 1% of ideal 'dry' weight. Six
patients received beta-adrenergic blocking agents (atenolol 50
mg alternate days to 100 mg daily). No patients received diu-
retics. One patient had 7.5 mg prednisolone daily, Five female
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Table 1. Serum lipid concentrations (values in mean SD) and lipoprotein patterns in normal subjects and hemodialysis patients
Male subjects
Diff.a
(A, B)
Female subjects
Normal
(A)
Hemodialysis
(B)
Normal
(C)
Hemodialysis
(D)
Diff.a
(C, D)
Number
Age, years
TC, mmoleslliter
TO, mmoles/liter
HDL-C, mmoleslliter
Hepatic lipase,
moles FFA/ml/hr
Lipoprotein lipase,
pmoles FFAImI/hr
Lipoprotein pattern
Normal
TypeIl
Mid-band'
Type IV
TypeV
52
38 10
54.6 1.15
1.39 0.84
1.08 0.27
22.5 5.7
(N = 23)
5.52 2.03
(N = 23)(N = 47)
40
5
2
0
0
53
39 13
5.09 1.21
2.70 1.99
0.70 0.20
14.6 5.4
(N = 32)
2.52 0.98
(N = 32)(N = 53)
14
2
23
12
2
—
NS
NS
P < 0.001
P < 0.001
P < 0.01
P < 0.001
—
P < 0.001
—
P < 0.001
P < 0.001
—
43
35 14
5.39 1.27
1.02 0.56
1.24 0.27"
14.0 5.2"(N = 17)
6.81 l.54b
(N = 17)(N = 39)
35
2
2
0
0
39
39 15
6.07 1.34
3.35 3.12
0.87 0.29"
10.7 4.8b
(N = 27)
2.37 1.18
(N = 27)(N = 39)
6
8
15
8
2
—
NS
P < 0.05
P < 0.001
P < 0.001
P < 0.05
P < 0.001
—
P < 0.001
—
P < 0.001
P < 0.01
—
Differences between the groups were evaluated by unpaired Student's t test, or, in the case of lipoprotein patterns, by means of x2 test.
b The value was significantly different from the corresponding value in males.
Origin
Interphase between stacking
and running gels
VLDL
Mid-band'
LDL
HOL
Fig. 1. Plasma lipoprotein electrophoretic patterns of uremic plasma on polyacrylamide gel. Patterns from left to right are: normal, note the faint
VLDL band; type ha, note that both VLDL and LDL bands are heavily stained; mid-band, note the discrete band between VLDL and LDL; type
IV, note that the VLDL band is heavily stained and the LDL band is practically invisible; type V, note the heavy chylomicronemia which produces
the meniscus. The gels are not perfectly aligned because the patterns were not obtained during the same run of electrophoresis.
patients were given low-dose estrogen continuously to prevent
blood loss due to menstruation. These medications were not
discontinued prior to the study. Dietary assessment in 63 pa-
tients revealed that the average diet provided about 2000 cal
and contained about 60 g protein. The caloric contributions of
carbohydrates and fats were roughly equal, that is, 45 and 42%,
respectively.
Blood samples after overnight fasting were collected at least
24 hr after dialysis to minimize the effect of heparinization on
plasma lipids. Serum cholesterol (TC) (Technicon Method No
SE 400 40 FC6) [10], serum triglyceride (TG) (Technicon
Method No SF 400 39 PA6) [11], and high-density lipoprotein
cholesterol (HDL-C) concentrations after precipitation of very-
low-density and low-density lipoproteins (VLDL and LDL)
with sodium phosphotungstate and magnesium chloride [12,
13], were measured enzymatically on an autoanalyzer (Techni-
con Instruments Corporation, Tarrytown, New York). If
chylomicrons floated on top of the supernatant containing
HDL, they were taken off by means of a pipette; the sample
re-centrifuged until a clear supernatant was obtained. Plasma
samples collected in EDTA were electrophoresed on p0-
lyacrylamide gel [14]. Fifty-nine patients had blood taken 15
mm after an intravenous dose of heparin (100 U/kg) for the
measurement of hepatic lipase and lipoprotein lipase activities
using the substrate-specific method of Nilsson-Ehle and Ek-
man [15] with the modification that Intralipid was used instead
of triolein and physiological concentrations of calcium were in-
cluded to optimize the conditions for lipoprotein lipase activity
[16].
Briefly, in the preparation of substrate for hepatic lipase,
e
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4.18 ml of 10% Intralipid pre-diluted 1:20 with 0.2 M Tris/HCI
buffer (pH 9) was added to 0.08 mole glycerol tn (9, 10(n)-3H)
oleate (sp act 500 mCi/mmole) which had been dried under ni-
trogen. Fatty acid-free bovine albumin (1.2 ml of 2%) was
added and the mixture sonicated on ice bath using a 150-watt
disintegrator (MSE Soniprep). In the preparation of substrate
for lipoprotein lipase, 4.8 ml of 10% Intralipid prediluted 1:10
with 0.2 M Tris/HCI buffer (pH 8) was added to 0,08 imole
glycerol tn (9, lO(n)3H) oleate (sp act 500 mCi/mmole). After
sonication of the mixture, 0.6 ml of 4% fatty acid-free bovine
albumin and 0.6 ml of pooled normal serum were added and the
emulsion was vortex-mixed. In the assay of hepatic lipase,
post-heparin plasma was pre-diluted 1:10 with 0.2 M Tris/HCI
buffer (pH 9, containing 2 M NaC1). For the measurement
of lipoprotein lipase, the plasma was pre-diluted 1:2 with
0.2 M Tris/HC1 buffer (pH 8, containing 6.94 mmoles/liter
CaCI2 2H20); 0.1 ml of the pre-diluted plasma was added
to 0.1 ml of the appropriate substrate, and the mixture was
incubated at 37°C for 30 mm. The reaction was terminated
by the addition of 3.2 ml of chloroform:methanol:heptane
(125: 141:100, v/v/v) mixture. Potassium borate buffer (1.0 ml,
pH 10.5) was added. The mixture was centrifuged at 2000 rpm
for 15 mm and 0.5 ml of the upper phase was transferred to 5
ml of Instagel in scintillation counting vials; the radioactivity
was counted. Total release of free fatty acids (FFA) was cal-
culated after correction for recovery and quenching and the en-
zyme activity was expressed in micromoles of FFA released
hr 'ml of post-heparin plasma. The efficiency of fatty acid
extraction was 75%. The inter-assay coefficient of variation for
hepatic lipase in aliquots of the same plasma sample measured
on ten separate occasions was 4.75% and that for the corre-
sponding lipoprotein lipase was 5.4%. Although a 'standard'
post-heparin plasma sample was included in some of the as-
says for quality control, the final enzyme activities were not
corrected for the inter-assay variation which, as noted above,
was negligible. Throughout the study, mucosal sodium heparin
was used. The dose of heparin was so chosen because it had
been shown [8] to produce maximal release of the lipolytic
enzymes; such doses were often used during conventional
hemodialysis.
Total lipolytic activities (PHLA) were not measured in the
patients. Nevertheless, PHLA measured in 25 subjects ap-
proximated the sum of hepatic lipase and lipoprotein lipase ac-
tivities separately determined in aliquots of the same plasma
sample (PHLA = 22.0 3.5; HL + LPL = 21.0 3.4, mean
SD). The procedure adopted for measuring PHLA employed
a substrate which was sonicated in the presence of albumin for
hepatic lipase activity and included normal serum and calcium
chloride to optimize lipoprotein lipase activity. Tris/HCI buffer
with a pH of 8.6 was used because that was the pH used in pub-
lished methods for measuring PHLA [17].
Fifty-two male and 43 female volunteers with normal renal
function served as control subjects. Blood samples were taken
from all of them while they fasted for the measurement of TC,
TG, and HDL-C concentrations. Lipoprotein electrophoresis
was performed on 83 normal plasma samples. Of the control
subjects, 23 males and 17 females had plasma collected 15 mm
after an injection of 100 U/kg i.v. of heparin for the measure-
ment of hepatic lipase and lipoprotein lipase activities.
Several subjects (hemodialysis patients as well as normal
subjects) had intravenous fat tolerance tests performed on pre-
vious occasions. Fifteen minutes after injection of 100 U/kg i.v.
of heparin, an intravenous bolus (1 mllkg) of 10% Intralipid was
given. Blood samples were taken at 5-mm intervals for 30 mm
for the measurement of light scattering. The post-heparin frac-
tional clearance rates [18], designated K'2, were obtained from
the slopes of regression lines of light-scattering indices of se-
rial plasma samples against time in minutes. The plasma
sample obtained from each subject 15 mm after the intra-
venous dose of heparin and immediately before the bolus of In-
tralipid was stored at —20°C and later assayed for hepatic and
lipoprotein lipase activities.
One hemodialysis patient with gross fasting chylomicro-
nemia had serial blood samples taken after an intravenous in-
jection of heparin (100 U/kg). The serial plasma samples were
electrophoresed on polyacrylamide gel.
Results
The serum lipid concentrations and the post-heparin hepatic
lipase and lipoprotein lipase activities of normal subjects and
hemodialysis patients are given in Table 1. Hemodialysis pa-
tients had higher TG and lower HDL-C concentrations than did
their age and sex-matched control subjects. In control sub-
jects, a significant difference in the activities of the two en-
zymes existed between the two sexes: Males had higher he-
patic lipase and lower lipoprotein lipase activities than did
females. Both male and female hemodialysis patients had sig-
nificantly lower hepatic and lipoprotein lipase activities than
did age- and sex-matched control subjects. While the mean he-
patic lipase activity was higher in male than in female hemodi-
alysis patients, the mean lipoprotein lipase activities in male
and female hemodialysis patients did not differ significantly. Of
hemodialysis patients 2 1.7% (20/92) had typical type IV hyper-
lipoproteinemia with an increase in VLDL. Four of 92 (4.3%)
had type V hyperlipoproteinemia with varying degrees of fast-
ing chylomicronemia. Thirty-eight of 92 (41.3%) had an ab-
normal lipoprotein band mid-way between VLDL and LDL,
the 'mid-band' (Fig. 1). The prevalence of mid-band lipopro-
teins in hemodialysis patients was significantly different from
that in normal subjects (P < 0.001).
Serum HDL-C concentrations correlated inversely with the
log-transformed values of serum TG concentrations in both
sexes in normal subjects (r =
—0.38, P < 0.01 for males and r
=
—0.34, P < 0.05 for females) as well as in hemodialysis pa-
tients (r —0.49, P < 0.01 for males and r = —0,42, P < 0.05
for females). A hyperbolic relation between serum TG and
lipoprotein lipase activities is shown in Figure 2, although the
relationship appears to be heavily dependent on two data
points. It is conceivable that high serum triglyceride concen-
trations in these two patients might cause considerable dilu-
tion of the labelled triolein in lipoprotein lipase assay and spu-
riously lower in vitro lipolytic activity. Had this been the case,
the same two patients might be expected to have low hepatic
lipase activities. In fact their hepatic lipase activities were nor-
mal, that is, 30.8 and 14.7, respectively. When the log-trans-
formed values of serum TG concentrations were considered, a
moderate degree of correlation between these and lipoprotein
lipase activities could be demonstrated in normal males (r =
—0.68, P < 0.001), male hemodialysis (r = —0.46, P < 0.01)
as well as female hemodialysis (r =
—0.59, P < 0.01) patients
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even when the patients with chylomicronemia were excluded.
A positive correlation between HDL-C concentrations and
lipoprotein lipase activities in normal males and male hemodi-
alysis patients is shown in Figure 3. A similar correlation could
also be demonstrated for female subjects (r = 0.57, P < 0.02
for control subjects and r = 0.38, P < 0.05 for hemodialysis
patients). Hepatic lipase activities did not correlate with any of
the other parameters of lipid metabolism.
Table 2 shows the mean values of serum lipid concentra-
tions as well as hepatic and lipoprotein lipase activities of he-
modialysis patients grouped according to their lipoprotein pat-
terns. Type IV patients had significantly lower lipoprotein
lipase activities than did patients with normal lipoprotein pat-
tern. Type V patients had very low lipoprotein lipase activities
but relatively normal hepatic lipase activities. Patients with
mid-bands had significantly lower hepatic lipase activities than
did those with the type IV pattern. Patients with normal
lipoprotein patterns had the lowest mean serum cholesterol
(difference from type II, P < 0.01; from type IV, P < 0.02),
lowest mean serum triglyceride concentration (difference from
type II and from IV, P < 0.01, difference from mid-bands, P
< 0.05) and the highest mean HDL-C concentration (differ-
ence from type IV and mid-bands, P < 0.05). The mean serum
cholesterol, triglyceride, and HDL-C concentrations of pa-
tients with mid-bands did not differ significantly from the cor-
responding values of the other hyperlipoproteinemic groups.
Type V patients were not considered in these comparisons be-
cause of the small number of patients.
Table 3 shows the prevalence of mid-bands in hemodialysis
patients with normal or low activities of hepatic lipase and
lipoprotein lipase. Patients with low hepatic lipase activities
had a significantly higher prevalence of mid-bands (P < 0.01)
than did those with normal hepatic lipase activities. No differ-
ence in the prevalence of mid-bands was seen between pa-
tients with normal and those with low lipoprotein lipase activi-
ties. Hepatic lipase activities did not correlate with any other
2 4 6 8 10 12
Lipoprotein lipase activity, p.moles FF4/rn I/hr
Fig. 3. Correlation between lipoprotein lipase activities and HDL-cho-
lesterol concentrations in male normal subjects (0) and male hemodi-
alysis patients (•).
parameters of lipid metabolism. Figure 4 demonstrates a sig-
nificant positive correlation between in vitro lipoprotein lipase
activities and in vivo post-heparin K'2 of Intralipid. Figure 5
illustrates the change in lipoprotein electrophoretic patterns in
a patient with type V hyperlipoproteinemia who was given an
intravenous injection of heparin. The increase in the staining of
HDL band is very striking.
Discussion
The finding of high concentrations of TG and low concen-
trations of HDL-C confirm the results of other investigators [1,
19], and our previous study in a smaller cohort of the same
population of hemodialysis patients in which we reported that
serum lipid (TC, TG, and HDL-C) concentrations did not cor-
relate with the duration of dialysis or adiposity indices calcu-
lated from height and weight [20]. Although for ethical reasons
the low dose estrogens had not been discontinued prior to the
study, it is most unlikely that the inclusion of the few women
who received such therapy will affect the validity of interpre-
tation of the present results. The positive correlation between
lipoprotein lipase activities and HDL-C concentrations is simi-
lar to that between adipose tissue lipoprotein lipase and HDL-
C reported in non-uremic subjects [21]. The inverse relation be-
tween HDL-C concentrations and log-transformed TG concen-
trations, also observed in non-uremic subjects [22], provides
further evidence of the close association between HDL and TG
metabolism. We have previously reported a positive correla-
tion between HDL-C concentrations and post-heparin K'2 of
Intralipid in hemodialysis patients [23] and suggested that the
relation might reflect rate-limiting effects of activator (apopro-
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Fig. 2. Relation between lipoprotein lipase activities and serum TG
concentrations in hemodialysis patients. Open circles (0) represent fe-
male and closed circles (•) male patients. The curve has not been fitted
mathematically. While more points with lipoprotein lipase activities be-
low 1.0 mmoles/liter FFA/ml/hr or serum TG concentrations greater
than 10 mmoles/liter would be desirable, the data are at least sugges-
tive of a hyperbolic relation between the two parameters of tri-
glyceride metabolism.
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Table 2. Mean values of serum lipid concentrations and post-heparin lipolytic activities in hemodialysis patients grouped according to their
lipoprotein electrophoretic patterns
Lipoprotein patterns
Normal Type II 'Mid-band' Type IV Type V
Number of patients 20 10 38 20 4
Serum cholesterol, mmoleslliter 4.77 7.04 5.36 5.79 5.46
Serum triglyceride, mmoleslliter 1.57 3.43 2.68 3.17 10.76
HDL-cholesterol, mmoleslliter 0.93 0.82 0.73 0.67 0.61
Hepatic lipase, 12.4 8.7a 11.4 16.2b 20.0
,umoles FFA/ml/hr (N = 12, 8M:4F) (N = 7, 2M:5F) (N = 24, l4M:IOF) (N = 12, 6M:6F) (N = 4, 2M:2F)
Lipoprotein lipase, 3.24 2.48 2.40 2.18' 1.12
/.Lmoles FFAImlIhr (N = 12, 8M:4F) (N 7, 2M:5F) (N = 24, l4M:IOF) (N = 12, 6M:6F) (N = 4, 2M:2F)
a Apparently, type II patients had the lowest mean value of hepatic lipase activity which is probably because of the greater number of female
patients (who tend to have lower hepatic lipase activities) included in this group.
b This value is significantly different (P < 0.05) from the corresponding value in patients with 'mid-bands.'
This value is significantly different (P < 0.05) from the corresponding value in patients with normal patterns. Note that those patients with
otherwise types II or IV patterns, but showing the presence of 'mid-bands,' were classified as having 'mid-band' dyslipoproteinemia.
Hepatic lipas
activity
Normal
e
Low
Lipoprotein lip
activity
Normal
ase
Low
No. of patients with
'mid-bands' 5 19 11 13
Total no. of patients 26 33 24 35
Percentage 19.2 57.6 45.8 37.1
Difference P < 0.01 P = NS
('normal' vs. 'low')
a Hepatic lipase activities below 14.6 imoles FFA/ml/hr in male
patients or 10.7 moles FFA/ml/hr in female patients (the respective
mean values of male and female hemodialysis patients) were considered
'low' and those above considered 'normal.' Similarly, lipoprotein lipase
activities below 2.52 .tmoles FFAImI/hr in male hemodialysis patients
or below 2.37 mo1es FFA/ml/hr in female hemodialysis patients were
regarded as 'low' and those above as 'normal.' Differences were
evaluated by x2 test.
tein-Cil) concentrations on lipoprotein lipase activity, as HDL
acts as a reservoir for apoprotein-CIl [24]. During the break-
down of chylomicra and VLDL, surface apoproteins including
apoprotein-A are transferred from the TG-rich lipoproteins to
HDL [25], a fact clearly demonstrated by the striking change
in plasma lipoprotein electrophoretic patterns in the type V
hyperlipoproteinemic patient after the intravenous administra-
tion of heparin. Thus, the correlation between HDL-C concen-
trations and lipoprotein lipase activities measured in vitro, or
measured in vivo as post-heparin K'2 of Intralipid, is best in-
terpreted as reflecting the influence of the catabolism of TG-
rich lipoproteins on the plasma HDL pool. The low lipoprotein
lipase activities in hemodialysis patients could be conceived as
the cause of the low HDL-C concentrations in these patients.
The difference in hepatic lipase and lipoprotein lipase activi-
ties between males and females has been reported in non-ure-
mic subjects [26]. The present study has demonstrated low ac-
tivities of both hepatic and lipoprotein lipases in hemodialysis
patients. Furthermore, the normal difference in lipoprotein
lipase activities between the two sexes disappeared in hemodi-
alysis patients. Other investigators [3, 4] have reported a se-
lective deficiency of hepatic lipase in uremic patients. Only 11
I I I I I
2 4 6 8 10
Lipoprotein lipase activity, mo/es FF4/rn//hr
Fig. 4. Correlation between lipoprotein lipase activities and post-
heparin K'2 of Intralipid. Open circles (0) represent normal subjects
and closed circles (•) hemodialysis patients. The values of K'2 were
obtained by intravenous fat tolerance tests after heparin administra-
tion. Plasma samples obtained after heparin injection but before the
intravenous bolus of Intralipid were assayed for lipoprotein lipase and
hepatic lipase activities using Intralipid as the substrate.
patients were studied by one group, and the two lipases were
determined by a difference method [4]. Another group [3]
measured the two lipases with a specific method but unfortu-
nately had failed to separate the patients into two groups ac-
cording to their sexes. These results are therefore not directly
comparable to those obtained in the present study.
Table 3. Prevalence of 'mid-band' lipoproteins in hemodialysis
patients with 'normal' or 'low' enzyme activities of hepatic and
lipoprotein lipasea
0 0
= 0.82
P < 0.001
14 —
12 —
10—
8—
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0 5 10 15 20 40 nature of this mid-band, it is reasonable to presume that it rep-
resents remnant particles or intermediate-density lipoproteins
(IDL) because the separation of lipoproteins on polyacrylam-
ide gel depends largely on molecular sieving [30]. A similar ab-
normal lipoprotein in uremic plasma has been previously re-
ported [3 1—33]. Minamisono et al [31] have provided evidence
that an abnormal lipoprotein on polyacrylamide gel electropho-
resis of uremic plasma is indeed IDL.
Although there was no significant correlation between he-
patic lipase activities and other parameters of lipid metabo-
lism, the prevalence of mid-band lipoproteins was significantly
higher in patients with low hepatic lipase than in those with
normal hepatic lipase activities. Such a difference in the preva-
lence of mid-band lipoproteins could not be shown between pa-
tients with low and those with normal lipoprotein lipase activi-
ties. Furthermore, patients with mid-bands had significantly
lower hepatic lipase activities than did those with a type IV
pattern. The inverse correlation between TG in LDL1 and he-
patic lipase activities already noted [4] is consistent with a role
of hepatic lipase in the breakdown of remnant particles. Al-
though it is tempting to suggest that the low hepatic lipase ac-
tivities were responsible for the accumulation of abnormal
lipoproteins which electrophoresed as mid-bands on poly-
acrylamide gel, without knowledge of the triglyceride and cho-
lesterol content of the individual lipoproteins or the composi-
tion of their constituent apoproteins, it is impossible to be sure
whether or not these are indeed IDL. The correlation [6] be-
tween hepatic lipase activities and serum TC concentrations
could not be confirmed by our findings.
We conclude that the low activities of both hepatic lipase and
lipoprotein lipase in hemodialysis patients contribute to the
lipid abnormalities in these uremic subjects. While the low
lipoprotein lipase activities (due to inhibition of adipose tissue
lipoprotein lipase by some uremic toxin [34] or insulin resist-
ance resulting in diminished releasable enzyme stores in sub-
jects exposed to repeated systemic heparinization?) largely de-
termine the severity of the hypertriglyceridaemia and cause the
low HDL-C concentrations, the low hepatic lipase activities
may be responsible for the accumulation of mid-band lipopro-
teins. Further work is in progress to characterize the chemical
composition of the mid-bands. Although lipoprotein lipase ac-
tivities were inversely correlated with log-transformed values
of serum TG concentrations, the considerable variation in se-
rum TG concentrations at a given level of lipoprotein lipase ac-
tivity suggests that other factors such as triglyceride produc-
tion may also play a role in the pathogenesis of hyperlipidemia
in some uremic patients [201.
Reprint requests to Dr. M. K. Chan, Department of Medicine, Uni-
versity of Hong Kong, Queen Mary Hospital, Pokfulam Road, Hong
Kong
Fig. 5. The change in plasma lipoprotein electrophoretic patterns in a
type V hyperlipoproteinemic hemodialysis patient after heparin injec-
tion. Note the gross chylomicronemia forming the dark meniscus in the
stacking gel. The HDL band was very faint, but the staining sharply
increased after the patient was given an intravenous injection of he-
parin (100 U/kg). Electrophoresis was performed on polyacrylamide
gel. The numerals indicate time in minutes after heparin administra-
tion. The two pre-heparin fasting samples were taken on different days.
The role of lipoprotein lipase in the catabolism of triglycer-
ides is well-documented, for example, injection of an anti-
serum to lipoprotein lipase in animals produces a precipitous
rise in serum TG concentrations [27], and subjects deficient in
lipoprotein lipase exhibit gross fasting chylomicronemia [7].
The relation between serum TG concentrations and lipopro-
tein lipase activities in hemodialysis patients appears to be hy-
perbolic. We have previously reported a similar relationship
between serum TG concentrations and in vivo post-heparin
K'2 of Intralipid in hemodialysis patients [231. The inverse cor-
relations between lipoprotein lipase activities and log-trans-
formed values of serum TG concentrations, the demonstration
[23] that a post-heparin K'2 of Intralipid of 4%/mm separated
normo- from hyper-triglyceridemic hemodialysis patients and
the positive correlation between the in vitro lipoprotein lipase
activities and the in vivo post-heparin K'2 of Intralipid—all
suggest that impaired triglyceride catabolism as a result of low
lipoprotein lipase activities is instrumental in the pathogenesis
of uremic hypertriglyceridemia. Thus, the present study con-
firms and extends the observations of other investigators [6,
28]. The exact role of hepatic lipase in lipoprotein metabolism
remains conjectural. It is evident that hepatic lipase activities
did not always vary in the same direction with lipoprotein
lipase. The four patients with type V hyperlipoproteinemia had
very low lipoprotein lipase activities but high hepatic lipase ac-
tivities. It has been suggested that hepatic lipase acts on rem-
nant particles which are avidly trapped by the liver [29]. In vi-
tro, lipoprotein lipase prefers chylomicra as substrate while he-
patic lipase hydrolyses remnant particles more effectively. In
this context, the frequent finding of a lipoprotein band midway
between VLDL and LDL is particularly interesting. Even
though ultracentrifugation has not been performed to define the
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